TNSN98174A1 - SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS. - Google Patents

SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS.

Info

Publication number
TNSN98174A1
TNSN98174A1 TNTNSN98174A TNSN98174A TNSN98174A1 TN SN98174 A1 TNSN98174 A1 TN SN98174A1 TN TNSN98174 A TNTNSN98174 A TN TNSN98174A TN SN98174 A TNSN98174 A TN SN98174A TN SN98174 A1 TNSN98174 A1 TN SN98174A1
Authority
TN
Tunisia
Prior art keywords
naphthalenes
similar compounds
substituted tetrahydro
tetrahydro
compounds
Prior art date
Application number
TNTNSN98174A
Other languages
French (fr)
Inventor
Hilmar Bischoff Dr
Michael Logers Dr
Stoltefub Jurgen
Gunter Schmidt Dr
Klaus-Dieter Bremm Dr
Delf Schmidt Dr
Holger Paulsen Dr
Stephan Nicholas Muller Dr
Paul Naab Dr
Carsten Schmeck Dr
Arndt Brandes Dr
Stephen Antons Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TNSN98174A1 publication Critical patent/TNSN98174A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48—Halogenated derivatives
    • C07C35/52—Alcohols with a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/192—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

DES TETRAHYDRO-NAPHTALENES ET DES COMPOSES ANALOGUES SONT PREPARES PAR REDUCTION OU CONDENSATION DE SUBSTITUANTS FONCTIONNELS APPROPRIES DANS DES TETRAHYDRO-NAPHTALENES SUBSTITUES ET DES COMPOSES ANALOGUES SELON DES METHODES CLASSIQUES ET PAR CONVERSION DES GROUPES FONCTIONNELS EN LES GROUPES RECHERCHES SELON CES METHODES. LES COMPOSES DE LA PRESENTE INVENTION CONVIENNENT POUR ETRE UTILISES EN TANT QUE COMPOSES ACTIFS DANS DES SPECIALITES PHARMACEUTIQUES, EN PARTICULIER DANS DES SPECIALITES PHARMACEUTIQUES DESTINEES A TRAITER L'ARTERIOSCLEROSE ET EGALEMENT LES DYSLIPIDEMIESTETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS ARE PREPARED BY REDUCTION OR CONDENSATION OF SUITABLE FUNCTIONAL SUBSTITUTES IN SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPONENTS ACCORDING TO CLASSICAL AND CONVERSION GROUP-BASED METHODS. THE COMPOUNDS OF THE PRESENT INVENTION ARE SUITABLE FOR USE AS ACTIVE INGREDIENTS IN PHARMACEUTICAL SPECIALTIES, IN PARTICULAR IN PHARMACEUTICAL SPECIALTIES FOR TREATING ARTERIOSCLEROSIS AND ALSO DYSLIPIDEMIA

TNTNSN98174A 1997-09-18 1998-09-16 SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS. TNSN98174A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19741050 1997-09-18
DE19832159A DE19832159A1 (en) 1997-09-18 1998-07-17 New tetrahydronaphthalene derivatives

Publications (1)

Publication Number Publication Date
TNSN98174A1 true TNSN98174A1 (en) 2005-03-15

Family

ID=7842736

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98174A TNSN98174A1 (en) 1997-09-18 1998-09-16 SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS.

Country Status (9)

Country Link
AR (1) AR015453A1 (en)
DE (2) DE19832159A1 (en)
GT (1) GT199800147A (en)
PA (1) PA8459801A1 (en)
PE (1) PE119599A1 (en)
SV (1) SV1998000115A (en)
TN (1) TNSN98174A1 (en)
UY (1) UY25185A1 (en)
ZA (1) ZA988492B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60233874D1 (en) 2001-06-22 2009-11-12 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS CONTAIN DISPERSIONS FROM MEDICAMENTS AND NEUTRAL POLYMERS
KR100759635B1 (en) 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 Pharmaceutical compositions of adsorbates of amorphous drug
CL2004001884A1 (en) 2003-08-04 2005-06-03 Pfizer Prod Inc DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS.
US8617604B2 (en) 2005-02-03 2013-12-31 Bend Research, Inc. Pharmaceutical compositions with enhanced performance
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Also Published As

Publication number Publication date
AR015453A1 (en) 2001-05-02
DE19832159A1 (en) 1999-03-25
DE59812757D1 (en) 2005-06-02
ZA988492B (en) 1999-03-31
PE119599A1 (en) 1999-12-30
UY25185A1 (en) 1999-03-15
SV1998000115A (en) 1999-05-25
PA8459801A1 (en) 2000-05-24
GT199800147A (en) 2000-03-11

Similar Documents

Publication Publication Date Title
ATE259215T1 (en) COMPOSITION FOR REGULATING SKIN APPEARANCE
CA2330500A1 (en) Pharmaceutical compositions capable of being gelled
WO1999058555A3 (en) Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
CA2208243A1 (en) Deodorant composition comprising a water-soluble zinc salt as odor absorbing agent
GR3003350T3 (en) Process for neutralizing unpleasant odours of animal excreta
TNSN95061A1 (en) OXALYLAMINO-BENZOFURAN AND BENZOTHIENYL DERIVATIVES
BR9807577A (en) Method to prevent and delay the onset of Alzheimer's disease and its composition
BR0115427A (en) Compound, pharmaceutical composition, methods for inhibiting the release of beta-amyloid peptide and / or its synthesis, for treating Alzheimer's disease, and for preventing the disease and the progress of Alzheimer's disease, and, use of a compound.
EP0911321A3 (en) Compounds for the treatment of osteoporosis
MD970178A (en) The invention relates to a process for obtaining and purifying phytosterol compositions from cellulose lesions, which includes the extraction of the precipitate from the cellulose lesion having a consistent precipitate. A process for purifying and preparing phytosterol compositions from pulping soap comprises extracting from the pulping soap a creamy precipitate and purifying this precipitate. Claims: 13
TNSN99133A1 (en) IMPROVED PROCESS FOR THE PREPARATION OF SCHIFF BASES AND PRODUCTS THUS OBTAINED
ATE205086T1 (en) USE OF THE CHELATING AGENT CLIOQUINOL FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ATE71629T1 (en) METHYLENEPHOSPHONELKYLPHOSPHINATES, PHARMACEUTICAL PREPARATIONS AND METHODS FOR THE TREATMENT OF ABNORMAL CALCIUM AND PHOSPHATE METABOLISM.
WO1998058911A3 (en) Prostaglandin agonists
FI945839A (en) Aqueous solution of inclusion complexes of benzothiophene compounds and water-soluble cyclodextrins and their pharmaceutical formulations and method
DE69802113T2 (en) COMPOSITIONS FOR INCREASING THE CONCENTRATION AND / OR MOBILITY OF SEED CELLS IN HUMANS
TNSN00139A1 (en) SUBSTITUTED PHENOXYACETIC ACIDS
BR9711225A (en) Transdermal propentophylline compositions for the treatment of alzheimer's disease
TR199700711T1 (en) Formulation that enters the body by passing through the skin.
TNSN98174A1 (en) SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS.
EP0801049A3 (en) Cyclopentanebutanol derivatives as odorants
DE69635305D1 (en) USE OF ANTI-INTERLEUKIN-9 ANTIBODY FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ASTHMA
BR0115424A (en) Compound, pharmaceutical composition, methods for inhibiting the release of beta-amyloid peptide and / or its synthesis, for treating alzheimer's disease, for preventing alzheimer's disease, and for inhibiting the progress of alzheimer's disease, processes for preparing the compound , and to prepare lactams, and, use of compound
BG105275A (en) Tan-1057 derivatives
NZ326345A (en) Composition containing diosgenin